Pre-Clinical Outsourcing
Catalent builds $20M expansion for German clinical supply facility
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...
April 06, 2023 | News
Bridgewest Group launches NovaCina, new sterile injectable CDMO
The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...
April 05, 2023 | News
Veranova Proposes Closure of Annan Facility
Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product por...
March 27, 2023 | News
TransCure bioServices delivers CDX mouse models to advance AML preclinical studies
TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cance...
March 07, 2023 | News
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck
In addition, Aqilion is eligible to receive potential development and commercialization milestones up to over EUR 950 million and tiered royaltie...
February 17, 2023 | News
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...
February 10, 2023 | News
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...
September 30, 2022 | News
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...
August 10, 2022 | News
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...
August 09, 2022 | News
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...
August 04, 2022 | News
Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan
Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition o...
July 01, 2022 | News
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes
WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-...
June 06, 2022 | News
ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U.S
MVR-T3011, ImmVira's proprietary 3-in-1oncolytic herpes simplex virus ("oHSV"), is a novel genetically engineered oHSV which aims to achieve the ...
April 20, 2022 | News
Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development
CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...
March 08, 2022 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
